Offering Psychedelic Treatments Before Assisted Dying for Psychiatric Conditions
Christopher Poppe, Jan Christoph Bublitz, Dimitris Repantis
JAMA Psychiatry August 1, 2025 DOI: 10.1001/jamapsychiatry.2025.1457 (opens in new tab)
Summary
AI-generated from the abstractThe viewpoint argues that psychedelic treatment should be offered to individuals with psychiatric conditions as a form of life-preserving care prior to physician-assisted death, suggesting it may provide relief and reduce suffering, potentially altering the trajectory toward assisted death.
Study at a glance
| Characteristics | Viewpoint Peer reviewed |
|---|---|
| Population | Persons with psychiatric conditions considering physician-assisted death |
| Key finding | Psychedelic treatment may serve as life-preserving care for psychiatric patients before physician-assisted death. |
Abstract
This Viewpoint describes the benefits of providing psychedelic treatment to persons with psychiatric conditions as life-preserving care before physician-assisted death.